Healthcare companies Sanofi and GSK to seek Covid-19 vaccine regulatory approval
The logo of Sanofi is seen at the company's headquarters in Paris, France, April 24, 2020/ Reuters
Healthcare companies Sanofi and GSK said they intend to submit data from both their booster and Phase III efficacy trials as the basis for regulatory applications for a Covid-19 vaccine.
"We're very pleased with these data, which confirm our strong science and the benefits of our Covid-19 vaccine. The Sanofi-GSK vaccine demonstrates a universal ability to boost all platforms and across all ages," said Thomas Triomphe, executive vice president for Sanofi Vaccines.
Keep updated, follow The Business Standard's Google news channel
